EDITORIAL
Published on 29 Jul 2022
Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
doi 10.3389/fendo.2022.987648
- 1,174 views
- 1 citation
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Decoding Checkpoint Inhibitor-induced Endocrinopathies
Decoding Checkpoint Inhibitor-induced Endocrinopathies
6,310
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 14 Jul 2022
Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
doi 10.3389/fonc.2022.894015
- 2,130 views
- 12 citations
REVIEW
Published on 26 May 2022
Immune Related Adverse Events of the Thyroid – A Narrative Review
doi 10.3389/fendo.2022.886930
- 4,921 views
- 25 citations
REVIEW
Published on 03 Mar 2022
Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?
doi 10.3389/fonc.2022.798517
- 2,940 views
- 10 citations
CASE REPORT
Published on 31 Jan 2022
Alpelisib-Induced Diabetes Mellitus: Case Report, Pharmacodynamics and Management Considerations
doi 10.3389/fendo.2022.802612
- 4,147 views
- 7 citations
REVIEW
Published on 05 Nov 2021
Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
doi 10.3389/fendo.2021.764138
- 4,618 views
- 29 citations
Published in
Frontiers in Endocrinology
- Cancer Endocrinology
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Oncology
Cancer EndocrinologyOffline
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore
Impact
- 20kTopic views
- 13kArticle views
- 6,310Article downloads